Cambridge, MA, United States of America

Salvatore Alioto

USPTO Granted Patents = 2 

Average Co-Inventor Count = 9.6

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Salvatore Alioto: Pioneering Immunotolerance Research

Introduction

Salvatore Alioto is an inventive force located in Cambridge, MA, who has made significant contributions to the field of immunology. With a robust portfolio of two patents, he is recognized for his innovative research and development efforts aimed at advancing medical science.

Latest Patents

Salvatore Alioto's latest patents showcase pioneering techniques in immunotolerance. The first, titled "Tissue targeted immunotolerance with a CD39 effector - Methods and compounds for conferring site-specific or local immune privilege, such as to the skin," explores novel methods for enhancing immune responses while selectively protecting tissues. His second patent, "MAdCAM targeted immunotolerance - Methods and compounds for conferring site-specific or local immune privilege, such as targeting to a cell expressing MAdCAM," further illustrates his dedication to developing targeted immunological solutions.

Career Highlights

Currently, Salvatore Alioto is a key player at Pandion Operations, Inc., where he collaborates on innovative projects at the intersection of immunology and biotechnology. His work at Pandion distinguishes him in an industry that continually seeks breakthroughs in therapeutic strategies.

Collaborations

Throughout his career, Salvatore has worked alongside talented professionals, including Nathan Higginson-Scott and Lindsay J Edwards. These collaborations leverage diverse expertise to advance their shared goals in immunotolerance research, contributing to and enhancing Salvatore's innovative outputs.

Conclusion

Salvatore Alioto's contributions through his patents and collaborative efforts demonstrate his commitment to pushing the boundaries of immunotolerance research. His work at Pandion Operations, Inc. reflects a significant intersection of science and innovation, making it essential for the ongoing evolution of medical treatments. As he continues to forge new paths in immunology, his inventions have the potential to improve patient outcomes and shape the future of therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…